• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Corporate leverage returns to pre-pandemic levels

September 20, 2021 by David Barret Leave a Comment

September 20, 2021

By Yoruk Bahceli

(Reuters) – U.S. and European companies have marked another milestone in their road to recovery from COVID-19, seeing their debt levels relative to profits tumbling to the lowest since before the pandemic erupted in 2020.

Net leverage, an important gauge of a company’s financial health, refers to net debt as a proportion of EBITDA – earnings before accounting for interest, taxes, depreciation and amortization.

At U.S. companies rated investment-grade, it fell in the second quarter to the lowest since 2018, according to BNP Paribas, while European leverage is the lowest since 2019.

The trend is a good sign for corporate debt markets, where the lowest-rated segments are outperforming this year, signalling normalising credit quality.

“The earnings recovery has been much steeper than what we had initially had in mind, partly because the economy and corporate earnings have become increasingly COVID-immune,” said Viktor Hjort, global head of credit strategy at BNP Paribas.

Graphic: Corporate leverage at pre-pandemic levels https://ift.tt/3lIV8iy

Earnings at S&P 500 and STOXX 600 companies are already some 40% above pre-pandemic levels, according to Refinitiv, with the vast majority of companies beating forecasts.

Leverage has fallen fastest at U.S. firms with “junk” credit ratings, or below the BBB- threshold, where it is nearly at pre-pandemic levels, BNP’s data shows.

Kristjan Mae, analyst at asset manager Schroeders, said that while deleveraging at U.S. investment-grade companies was mostly down to strong earnings growth, junk or high-yield firms “have been taking active steps, as is illustrated by negative debt growth”.

As of August, U.S. high yield debt was down 1.3% from year-earlier levels, data from BofA shows.

“As some of the lower-rated companies have been under pressure to cut leverage, this is perhaps not a surprising development,” Mae wrote in a note.

Graphic: Total U.S. junk debt falls https://ift.tt/3nNU4g4

BNP Paribas data also shows that quick ratios – effectively an indication of how quickly a borrower can pay off short-term obligations with available liquidity – are well above pre-pandemic levels.

The U.S. quick ratio has dipped slightly from a 10-year high to 95%, but in Europe it is at the highest since 2005 at 84%, possibly due to regional companies’ unease about slower economic recovery.

“That speaks of corporates that haven’t fully recovered their confidence in the future, that are still acting as if there’s a bit of a pandemic going on, or not quite certain that they will have as much access to funding as they did pre-COVID,” Hjort said.

Companies worldwide are sitting on some $5.2 trillion in cash, a Janus Henderson report found in July, a result of spending caution and big precautionary borrowings during the pandemic months.

But spending on dividends and capex has increased, meaning cash balances should decline from here. Global capital expenditure is set for the best year since 2007, says S&P Global, predicting a 13% surge.

But the process is expected to be slower in Europe, which Hjort said could help the region’s corporate bonds outperform over the coming months.

Graphic: Corporate liquidity ratios remain elevated https://ift.tt/3AsDENw

(Reporting by Yoruk Bahceli; additional reporting by Danilo Masoni; editing by Sujata Rao and Nick Macfie)

Source Link Corporate leverage returns to pre-pandemic levels

David Barret
David Barret

Related posts:

  1. Tennis-Sabalenka defeats Mertens in straight sets in U.S. Open fourth round
  2. China’s export, import growth likely eased in Aug on COVID-19 cases, supply bottlenecks: Reuters poll
  3. Apple and Google bow to pressure in Russia to remove Kremlin critic’s tactical voting app
  4. Iran joins expanding Asian security body led by Moscow, Beijing

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • Alaska’s Wilderness At Risk As Trump Opens “Up To 82 Percent” Of National Reserve To Drilling
  • “Life-Changing” Gene Therapy Restores Hearing In Deaf Patients Within Weeks After Just One Shot
  • Man Broke Down Wall In His Basement And Discovered An Ancient Underground City That Once Housed 20,000 People
  • Same-Sex Penguin Couple Adopt And Raise Chick – And They’ve All Got 10/10 Names
  • Dolphins May Not “See” With Echolocation, But Instead “Feel” With It
  • Confirmed! Comet 3I/ATLAS Is Indeed An Interstellar Visitor, Quite Different From Its Predecessors
  • At 192, Jonathan – The Oldest Living Land Animal – Has Lived Through 40 US Presidents
  • 300,000-Year-Old Wooden Tools “Made By Denisovans” Discovered In China
  • Why Do Cats Eyes Glow? For The Same Reason Great White Sharks’ Do, Silly
  • G-astronomical News: Michelin-Starred Meal To Be Served On The ISS
  • In 2032, Earth May Witness A Once-In-5,000-Year Event On The Moon
  • Brand New Microscope Designed For Underwater Reveals Stunning Details Of Corals
  • The Atlantic’s Major Circulation Current Is Showing Worrying Signs, But Is Collapse Near?
  • “The Rings Held The Answer”: How We Finally Figured Out Saturn’s Day Length In 2019
  • Mystery Of Leonardo Da Vinci’s “Vitruvian Man” Solved By A Dentist And A Protractor
  • Asteroid Ryugu’s Latest Mineral Is As Weird As Finding “A Tropical Seed In The Arctic”
  • IFLScience The Big Questions: Are We Living Through A Sixth Mass Extinction?
  • Alien Abduction Or A Trick Of The Mind? A Down To Earth Explanation Of Close Encounters
  • Six Months Into Trump’s Presidency, Americans Report Record Low Pride In Being American
  • TikToker Unknowingly Handles Extremely Venomous Cone Snail And Lives To Tell The Tale
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version